Status:
COMPLETED
Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Platysmal Bands
Lead Sponsor:
Galderma R&D
Conditions:
Platysmal Bands
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
Interventional phase 2 study to evaluate safety and efficacy of abobotulinumtoxinA for the treatment of platysmal bands.
Eligibility Criteria
Inclusion
- Moderate to severe platysmal bands at maximum contraction as assessed by the Investigator using a photographic scale
- Platysmal bands graded as Level 3 or 4 at maximum contraction as assessed by the subject using a photographic scale
Exclusion
- Botulinum toxin treatment of any serotype below the lower orbital rim, in the neck or chest within 12 months prior to study treatment
Key Trial Info
Start Date :
September 25 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 4 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04080882
Start Date
September 25 2019
End Date
June 4 2020
Last Update
August 26 2022
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Galderma Research Site
Encinitas, California, United States, 92024
2
Galderma Research Site
Encino, California, United States, 91436
3
Galderma Research Site
Boynton Beach, Florida, United States, 33472
4
Galderma Research Site
Miami, Florida, United States, 33137